Dr. Michael Christopher Balduzzi, MD

Dr. Balduzzi practices at Allergy Immunology and Asthma Medical Group Inc. in Stockton, California.

Dr. Balduzzi's NPI, 1346565934, was assigned on April 7, 2010. Dr. Balduzzi graduated from New York Medical College in 2010. Dr. Balduzzi holds California license A135460.

Dr. Balduzzi's primary practice is Allergy Immunology and Asthma Medical Group Inc., at 4628 Georgetown Pl, Stockton, CA 95207 in San Joaquin County. The practice phone is (209) 478-6177.

Dr. Balduzzi's primary practice is Allergy Immunology and Asthma Medical Group Inc. in Stockton, California. The medical group on file is Allergy Immunology and Asthma Medical Group. Dmand AI also links Dr. Balduzzi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Balduzzi practices. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Balduzzi's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Balduzzi is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Balduzzi's licenses on file in 2 states: California and Florida.

Dmand AI lists asthma, chronic nasal allergies and hives among the conditions Dr. Balduzzi treats.

CMS data shows 14,716 Medicare services from Dr. Balduzzi across 16 procedure codes in 2024, for 657 Medicare patients. Medicare paid $296,371 for them. Every service was in an office.

CMS counts 657 Medicare patients who saw Dr. Balduzzi in 2024. The largest group is 65 to 74, with 317 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Balduzzi's median patient age at 35, with 57% women.

In 2024, Dr. Balduzzi wrote 3,079 Medicare Part D claims for 510 patients. 67% of them were for generic drugs. CMS names the drug for 2,920 of them, across 39 drugs with 11 or more claims each, at $778,458 in total drug cost. In 2023, CMS named 2,705 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Balduzzi for performance year 2024, reported as part of a group. Dr. Balduzzi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Balduzzi as offering telehealth.

CMS Open Payments shows 588 general payments to Dr. Balduzzi from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,008.

Dr. Balduzzi graduated from New York Medical College in 2010.

Dr. Balduzzi is in network with 10 carriers, including Blue Cross Blue Shield of Michigan, Aetna and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.